Molecular Basis of Thyroid Cancer 1st Editon 2010 Softbound at Meripustak

Molecular Basis of Thyroid Cancer 1st Editon 2010 Softbound

Books from same Author: NADIR R. FARID

Books from same Publisher: Springer

Related Category: Author List / Publisher List


  • Retail Price: ₹ 25255/- [ 5.00% off ]

    Seller Price: ₹ 23992

Sold By: Book Upload      Click for Bulk Order

Offer 1: Get ₹ 111 extra discount on minimum ₹ 500 [Use Code: Bharat]

Offer 2: Get 5.00 % + Flat ₹ 100 discount on shopping of ₹ 1500 [Use Code: IND100]

Offer 3: Get 5.00 % + Flat ₹ 300 discount on shopping of ₹ 5000 [Use Code: MPSTK300]

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

Free Shipping Available



Click for International Orders
  • Provide Fastest Delivery

  • 100% Original Guaranteed
  • General Information  
    Author(s)NADIR R. FARID
    PublisherSpringer
    Edition1st Edition
    ISBN9781441954763
    Pages444
    BindingSoftbound
    LanguageEnglish
    Publish YearOctober 2010

    Description

    Springer Molecular Basis of Thyroid Cancer 1st Editon 2010 Softbound by NADIR R. FARID

    Thyroid cancer is the fastest growing cancer in the U.S., especially among women. Given the relative success we have had in its treatment, there is a need to capitalize on it by better understanding the factors that underpin this malignancy, and exploring better strategies for diagnosis, treatment, and follow-up. To do so, we must take full advantage of the revolution in modern biology. This comprehensive volume addresses the needs of a broad readership. Against a backdrop of the complexity of the origins of cancer, pathology of thyroid tumors, including lymphomas, is discussed, as are molecular genetic lesions associated with spontaneous and radiation-related thyroid tumors, diagnostic tests available to surmise tumor subtypes (including a review of the potential of DNA micro arrays), advances in therapeutics (including recombinant hTSH superagonists, allowing for better treatment of well differentiated thyroid carcinoma and its imaging), and combinations of drugs that might influence the course of poorly differentiated and anaplastic thyroid cancer. In this book, we glimpse into the promise of gene therapy in the future management of otherwise lethal anaplastic and poorly differentiated thyroid tumors. The molecular genetics of medullary thyroid cancer is considered in depth, and malignancy is used as a showcase for genetic prediction and counseling. The Origin of Cancer.- The Pathology of Thyroid Cancer.- Thyroid Lymphomas.- Molecular Events in Follicular Thyroid Tumors.- Molecular Epidemiology of Thyroid Cancer.- Growth Factors and their Receptors in the Genesis and Treatment of Thyroid Cancer.- Biology of Ras in Thyroid Cells.- P53 and other Cell Cycle Regulators.- Abnormalities of Nuclear Receptors in Thyroid Cancer.- Matrix Metalloproteinases in Thyroid Cancer.- The Molecular Pathways Induced by Radiation and Leading to Thyroid Carcinogenesis.- TRK Oncogenes in Papillary Thyroid Carcinoma.- Thyroidal Iodide Transport and Thyroid Cancer.- Molecular Signaling in Thyroid Cancer.- Gene Expression in Thyroid Tumors.- Animal Models of Thyroid Carcinogenesis.- Diagnostic Molecular Markers in Thyroid Cancer.- Thyroid Cancer Imaging.- Past, Presence and Future of Thyroid-Stimulating Hormone (TSH) Superactive Analogs.- Pathobiology of Antineoplastic Therapy in Undifferentiated Thyroid Cancer.- Gene Therapy for Thyroid Cancer.- Familial Papillary Thyroid Carcinoma.- Ret Activation in Medullary Carcinomas.- From Genes to Decisions.